News
Filana Therapeutics
FLNA · NASDAQ
$0.6885+$0.0065 (+0.95%)TodayMarket closed ·
Prev close $0.682
Latest news
- NewsVandana Singh
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
- Press releaseGlobe Newswire
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
- Press releasePRNewswire
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseGlobe Newswire
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
- Press releaseGlobe Newswire
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
- Press releaseGlobe Newswire
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
- Press releaseGlobe Newswire
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
- Press releaseGlobe Newswire
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
- Press releaseGlobe Newswire
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.